Research with Protected Populations-

Vulnerable Participants
A; researchers and practitioners who conduct and participate in esearch studies, we must recognize that how research participants are engaged in studies is important in holding up ethical tenets. Both the Department of Health and Human Services (DHHS) and the U.S. Food and Drug Administration (FDA) give guidance on the concept of participant research vulnerability and its important to research ethics and to regulatory compliance (DHHS, 2001; FDA, 1998) .The DHHS states when some or all of the participants are likely to be vulnerable to coercion or undue influence, additional safeguards must be included to protect their rights and welfare (2001) . The DHHS gives examples of vulnerable participants, such as children, prisoners, pregnant women, handicapped, or mentally disabled persons, or economically or educationally disadvantaged persons (2001) . Workers are also included as vulnerable participants, primarily because of the possibility of coercion.
LEVELS OF VULNERABILITY
Vulnerable participants are those participants with diminished autonomy. Vulnerable individuals are considered to be those who are less able to defend themselves in a given setting or situation. Autonomy is generally broken down into two general elements in the bioethics literature.
The first element is mental capacity, the ability to understand and process information. The second element is voluntariness, freedom from the control or undue influence of others. Therefore, 
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participants have full autonomy when they have the capacity to understand and process information, and the freedom to volunteer for research without coercion or undue influence from others.
When a participant has limitations in either capacity or voluntariness, the participant is vulnerable. Examples of participants with lack of capacity are children and mentally disabled individuals. Examples of participants with a potential lack of voluntariness are participants in emergency situations, participants in hierarchical social structures, those who are economically or educationally disadvantaged, those who are marginalized in society, or participants with fatal or incurable diseases.
Within any population of vulnerable participants, individuals will have different levels of vulnerability. For instance, an individual may have diminished capacity to consent to participation in a study because of medication usage. It is the researcher's responsibility to assess capacity to consent prior to and during the research activity.
ABUSE OF PARTICIPANT RIGHTS
Participants who are vulnerable are more likely to have their rights abused in the following ways: • Physical Control. Vulnerable participants have been physically forced to participate in research at times and this represents a complete lack of voluntariness. A classic example is the use of Nazi Holocaust camp prisoners in research with an endpoint of participant death, such as the hypothermia studies. The participants had no choice whether or not to participate, and were under complete physical control.
• Coercion.The use of credible threat of harm or force to control another person is coercion. An example of coercion is a nursing home resident forced to choose between participating in a research study or leaving the nursing home, which was reported by the Office of the Inspector General (CollaborativeIRB Training Initiative,2005) .
• Undue Influence. The misuse of a position of confidence or power to lead another to make a decision that would not have been made otherwise is undue influence. An example is a health care provider's supportive response to a client's inquiry of whether the client should enter a research study, when, in fact, participation in the study is not in the client's best interest.
• Manipulation. Deliberate management of conditions or information in such a way as to lead others to make decisions they would not have made otherwise is considered manipulation. Examples of information manipulation include lying, withholding information, and exaggerating.
WORKPLACE RESEARCH
Coersion 10 Participate
Vulnerability of a worker as a research study participant can be referred to as "paycheck vulnerability." This occurs when studies are conducted in the workplace, especially in workplaces that pose real or perceived health and safety risks. Although each of these workplaces presents different scenarios for the employee and provides different study opportunities, "vulnerability" is related to the fact that the employer often promotes worker participation. The coercion potential lies in enrollment or non-enrollment for the study, as well as in loss of job, career, or benefits because of study findings. This vulnerability issue is often a low-profile and subtle issue. Unions also may promote worker participation with the expectation or hope that entitlements or benefits may follow study entry or study findings. This is another type of coercion.
Worker Risk
Worker risks from the effect of study findings may include: • Peer pressure. • Effects on individual benefits. • Possible threats to job retention. • Constraints to job advancements. • Impairment of family relationships. • Genetic issues affecting family and future health issues. • Ability to obtain and retain benefits and health insurance. • Financial implications for individuals, corporations, unions, or the government (e.g.,job loss, job restriction, health effect) as a result of the findings.
Balancing Risks and Benefits
Studies must be conducted to find critical answers to important problems. The health and safety of workers has been improved during the decades through workplace studies that broadened understanding of exposure pathways, control methodologies, and better detection techniques and devices. Some studies, however, may pose risk of harm to the physical, emotional, and economic well-being of the worker who elects to participate. Use of identifiable records without individual consent may create additional concerns.
All stakeholders involved in the research roles should he concerned about balancing the risks and benefits of the research. This means assuring accurate and full communication, appropriate scientific and ethical peer review, and dedication of resources to ethical issues. This balance of risk and benefits must also be applied in the conduct of the study. Stakeholders must be made APRIL 2005, VOL. 53, NO.4 Research &Ethics Corner aware of and participate in addressing the special needs and issues that apply to research using workers as study participants. This is particularly important because the number of worker-related studies has increased significantly in recent years because of employee health and safety fears and political concerns about exposures and risks to health.
The most important worker issue is privacy. Researcher access to confidential records adds to the vulnerability of workers who participate in workplace studies. Inappropriate release of individually identifiable health or other personal data could adversely affect a worker's job retention, insurance, and other employment-related benefits. In addition, employer ownership of employee records increases the risk for participants and makes studies more difficult to identify and manage as human participants research.
Minimizing Risk
To avoid or minimize these risks, study design must include adequate safeguards to protect the confidentiality of the information collected. A plan for the proper management of study data and records should clearly define: • Who is in control of the collected data. • Who is authorized and approved to access, use, or disseminate study data or results. • How use of data will be disclosed to the participant.
• What personal identifiers are used. • How the study results will be used or included in employee personnel or medical records.
Where more than one study is in progress with the same worker population, the risks to privacy and confidentiality are likely to increase, requiring even more diligence in the management of confidential data by investigators and by those monitoring the studies. Contact and consent materials and research plans must detail the risks, the safeguards, and the limits to confidentially provided by law.
Ethical Issues
The privacy situation currently is clouded by federal laws (HIPAA) and by many state laws that address specific situationssuch as genetictesting and privacy. Newer technologiesand electronic transmission of medical records exceed historic legal protections available for privacy. The research use of genetic data and biological samples creates additional complex ethical issues. Some ethicists and researchers have argued that genetic screening or testing should have no place in the worksite because of employment risk potentially associated with genetic screening or testing. At a minimum, when studies or medical monitoring include the collectionof biological samples, all planned future uses of those samples,identifiers, and the data obtained from the samples must be fully explained and accepted by the participant before beginning the study. Federal or state guidelines for using biological materialsin hospitalsor biomedicalstudies also apply for using such materials in studies in the workplace.
SUMMARY
Workers as study participants are a vulnerable population and additional considerations for their protection in research are needed. Issues related to invasion of privacy and coercion to participate in research studies must be carefully weighed and closely monitored. Worker autonomy must be fostered with respect to assuring that informed consent is given, meaning the information transferred is understood. Research will add to the body of know1edge and advance nursing practice, but one must always remember that risks and benefits must be balanced to achieve appropriate end results.
